中国医药集团旗下国药控股山西有限公司近日披露股权转让信息,拟转让国药控股山西明迪康医药有限公司60%股权,转让底价1299.81万元。 国药控股山西明迪康医药有限公司成立于2018年8月15日,注册及经营地位于山西省太原市小店区,主营药品、医疗器械批发,配套仓储、冷链配送等医药流通相关业务。 核心价值与优势 项目核心价值重点体现在资质条件、区位载体、业务延展性等方面。 一是具备齐全有效的...
Source Link中国医药集团旗下国药控股山西有限公司近日披露股权转让信息,拟转让国药控股山西明迪康医药有限公司60%股权,转让底价1299.81万元。 国药控股山西明迪康医药有限公司成立于2018年8月15日,注册及经营地位于山西省太原市小店区,主营药品、医疗器械批发,配套仓储、冷链配送等医药流通相关业务。 核心价值与优势 项目核心价值重点体现在资质条件、区位载体、业务延展性等方面。 一是具备齐全有效的...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.